Literature DB >> 8711434

Histaminergic regulation of NK-cells: protection against monocyte-induced apoptosis.

M Hansson1, A Asea, S Hermodsson, K Hellstrand.   

Abstract

Human natural killer (NK) cells (with CD3-/56+ phenotype) acquired features characteristic of apoptosis after incubation with autologous monocytes, as revealed by apoptotic nuclear morphology and degradation of DNA into oligonucleosomal fragments. The monocyte-induced apoptosis in NK-cells was prevented by the biogenic amine histamine at concentrations exceeding 0.1 microM. The protective effect of histamine was blocked by the H2-receptor (H2R) antagonist ranitidine but not by AH202399 A, a chemical control to ranitidine devoid of H2R affinity. It is concluded that histaminergic mechanisms may serve to protect NK cells from damage inflicted by products of the oxidative metabolism of monocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711434     DOI: 10.1046/j.1365-3083.1996.d01-291.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.

Authors:  Marc Buyse; Pierre Squifflet; Beverly J Lange; Todd A Alonzo; Richard A Larson; Jonathan E Kolitz; Stephen L George; Clara D Bloomfield; Sylvie Castaigne; Sylvie Chevret; Didier Blaise; Dominique Maraninchi; Kathryn J Lucchesi; Tomasz Burzykowski
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  Histaminergic effect on apoptosis of rat small intestinal mucosa after ischemia-reperfusion.

Authors:  T Yoshida; R Iwakiri; T Noda; K Okamoto; M Kojima; K Fukuyama; K Fujimoto
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 3.  Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

Authors:  K Hellstrand; M Brune; C Dahlgren; M Hansson; S Hermodsson; P Lindnér; U H Mellqvist; P Naredi
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

4.  Signalling through NK1.1 triggers NK cells to die but induces NK T cells to produce interleukin-4.

Authors:  A Asea; J Stein-Streilein
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

5.  Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.

Authors:  F Donskov; M Middleton; K Fode; P Meldgaard; W Mansoor; J Lawrance; N Thatcher; H Nellemann; H von der Maase
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.